Show simple item record

dc.contributor.authorBenajiba, Lina
dc.contributor.authorAlexe, Gabriela
dc.contributor.authorSu, Angela
dc.contributor.authorRaffoux, Emmanuel
dc.contributor.authorSoulier, Jean
dc.contributor.authorHemann, Michael
dc.contributor.authorHermine, Olivier
dc.contributor.authorItzykson, Raphael
dc.contributor.authorStegmaier, Kimberly
dc.contributor.authorPuissant, Alexandre
dc.date.accessioned2020-06-26T17:36:53Z
dc.date.available2020-06-26T17:36:53Z
dc.date.issued2018-11
dc.date.submitted2018-08
dc.identifier.issn0887-6924
dc.identifier.issn1476-5551
dc.identifier.urihttps://hdl.handle.net/1721.1/126001
dc.language.isoen
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/s41375-018-0291-xen_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePMCen_US
dc.titleCreatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AMLen_US
dc.typeArticleen_US
dc.identifier.citationBenajiba, L. et al. "Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML." Leukemia 33, 3 (November 2018): 800–804 © 2018 Springer Natureen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.relation.journalLeukemiaen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2019-12-05T17:38:07Z
dspace.date.submission2019-12-05T17:38:09Z
mit.journal.volume33en_US
mit.journal.issue3en_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record